Dr. Donald Kohn and Dr. Dennis Slamon

UCLA Broad Stem Cell Research Center physician scientists received two of the six CIRM Disease Team awards today. Drs. Dennis Slamon and Zev Wainberg with their University of Toronto colleague will initiate a Phase 1 clinical trial in the USA and Canada to test a new drug that targets cancer stem cells. Dr. Donald Kohn’s award will support the first-in-human trial of stem cell gene therapy for patients with sickle cell disease (SCD). Both projects will begin enrolling patients in early 2014.